Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 574.26B, Johnson & Johnson(JNJ) trades at $242.00. The stock has a price-to-earnings ratio of 21.84 and currently yields dividends of 2.2%.
On 2026-04-07, Johnson & Johnson(JNJ) stock traded between a low of $236.01 and a high of $242.00. Shares are currently priced at $242.00, which is +2.5% above the low and 0.0% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.24M, against a daily average of 6.8M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $141.50.
JNJ News
Stocks Near A Buy Zone Dow Jones Medical Giant Johnson & Johnson Eyes Latest Buy Point Licensing As the Dow Jones Industrial Average and other stock indexes tra...
Goldman Sachs keeps a Buy rating and $265 price target on Johnson & Johnson ahead of its Q1 earnings. The company had a “banner year” in 2025 with a remarkable...
Johnson & Johnson announced the launch of Varipulse Pro in Europe following CE Mark approval, further advancing its pulsed field ablation portfolio. This new pu...
Analyst ratings
59%
of 29 ratingsMore JNJ News
The first quarter was a difficult one for the S&P 500 and for investors as a variety of concerns circulated -- from worries about the revenue potential of artif...
$10,000 to Invest? Coca-Cola or Johnson & Johnson- One Stock Is More Reliable By Vandita Jadeja Published Apr 6, 12:15PM EDT Quick Read Johnson & Johnson (JNJ...
In late March 2026, Johnson & Johnson reported 52-week Phase 3 data showing its oral peptide ICOTYDE maintained high complete skin clearance rates and a consist...
Johnson & Johnson (JNJ) is in focus after two recent autoimmune updates, positive 52 week Phase 3 results for oral psoriasis drug ICOTYDE, and a US$500 million...
Key Points Defensive healthcare stocks such as Johnson & Johnson and CVS tend to outperform in recessions. Growth healthcare stocks offer higher risk and pote...
Johnson & Johnson (NYSE: JNJ) has agreed to an exclusive distribution and promotion deal with KYORIN Pharmaceutical for SIRTURO (Bedaquiline) in Japan. The com...
The S&P 500 Without Big Tech Is Quietly Beating the Full Index in 2026 By John Seetoo Published Apr 3, 9:18AM EDT Quick Read Defiance Large Cap ex-Mag 7 (XMAG...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.